JACC-Heart Failure

Papers
(The H4-Index of JACC-Heart Failure is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Wearable Remote Patient Monitoring Devices262
Reply136
Reply118
Examination of Initiation Patterns for Sacubitril/Valsartan Among Older Adults With HFrEF in the United States112
CHIEF Effects of Sodium Glucose Co-Transporter Inhibitors on Health-Related Quality of Life in Heart Failure106
Developing a System for Best Performance for Cardiac Transplantation104
Reply95
Reply94
Editorial Board91
Clinical Inertia Disturbs the Harmonious Treatment of Heart Failure88
Recognizing the Top Reviewers and Top Authors of JACC: Heart Failure87
Opportunities for Change in Home Health Care in Heart Failure84
Correction79
Unique Proteomic Signatures in Human Anthracycline-Induced Dilated Cardiomyopathy78
Clinical Implications of the P.V142I TTR Variant77
Myeloperoxidase in Heart Failure With Preserved Ejection Fraction76
Acute Decompensated Heart Failure in the Setting of Acute Coronary Syndrome73
Contemporary Trends in Heart Failure Mortality72
Racial and Genetic Differences in Presentation of Transthyretin Amyloid Cardiomyopathy With Impaired Left Ventricular Function70
Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype70
Eating to Prevent Both Heart and Planetary Failure68
Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status66
Early U.S. Heart Transplant Experience With Normothermic Regional Perfusion Following Donation After Circulatory Death64
Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia64
Tachycardia and Atrial Fibrillation-Related Cardiomyopathies63
Revisiting ICD Therapy for Primary Prevention62
Associations Between Urinary Metal Levels and Incident Heart Failure59
Geographic Variation in the Quality of Heart Failure Care Among U.S. Veterans58
From Loop Diuretics to Closed-Loop Decongestion58
Curing Ourselves of Toxic Positivity for Hospital-at-Home57
Pulmonary Artery Catheter Timing and Outcomes for Patients With Cardiogenic Shock56
Long-Term Effects of Sotatercept on Right Ventricular Function55
Predictors of Incident Heart Failure Diagnosis Setting55
Growth Hormone Replacement Therapy in Heart Failure With Reduced Ejection Fraction51
Full issue PDF51
Challenges Addressing Prognosis in Advanced Heart Failure49
The Impact of Social Determinants of Health on Timely Detection in Transthyretin Cardiac Amyloidosis49
Inhibiting Both Neprilysin and Phosphodiesterase Type 947
Framework for Analytical Validation of DHT-Based Actigraphy and Signal Measures in HF Trials46
Challenges in Cardiomyopathy Gene Therapy Clinical Trial Design46
NT-proBNP45
Clinical Utility of the H2FPEF Score in Patients With Early Atrial Fibrillation45
Genetically Proxied Interleukin-6 Signaling Inhibition and Heart Failure Risk45
GDF-15 in Cardiovascular Disease44
Peripheral Venous Pressure Measured With a Novel Miniature Transducer in Heart Failure Patients44
0.47315096855164